Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NextEra Energy, Inc. (NEE) vs Viatris Inc (VTRS) Price & Performance

NextEra Energy, Inc.Trade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

NextEra Energy, Inc. vs Viatris Inc — how do they compare? NextEra Energy, Inc. trades at $87.97 (market cap $183.53B), while Viatris Inc trades at $17.58 (market cap $19.79B). The key difference: NextEra Energy, Inc. is far larger — about 9.3× Viatris Inc's market cap, and Viatris Inc is trading nearer its 52-week high, NextEra Energy, Inc. nearer its low. Which is the better fit depends on your goals.

NEEVTRS
Market Cap
$183.53B$19.79B
Sector
UtilitiesHealth
52-Week High
$97.88$17.39
52-Week Low
$69.77$8.74
Enterprise Value
$285.94B$32.00B
Dividend Yield
2.83%2.83%

Returns comparison

Trailing returns across standard periods

About NextEra Energy, Inc.

NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.

Read more on NEE

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS